News
1d
Pharmaceutical Technology on MSNFDA free to pursue semaglutide compounders after latest court rulingDespite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...
Patients receiving preoperative semaglutide versus controls had similar median hemoglobin A1c levels before MBS and one year after MBS. Furthermore, both cohorts had a similar number of patients ...
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE Patients exploring weight-loss management strategies may elect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results